Advanced Healthcare Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 30, 2024
The
application
of
oncolytic
peptides
has
become
a
powerful
approach
to
induce
complete
and
long-lasting
remission
in
multiple
types
carcinomas,
as
affirmed
by
the
appearance
tumor-associated
antigens
adenosine
triphosphate
(ATP)
large
quantities,
which
jumpstarts
cancer-immunity
cycle.
However,
ATP
breakdown
product
is
significant
contributor
forming
immunosuppressive
tumor
microenvironment,
substantially
weakens
peptide-driven
immunotherapy.
In
this
study,
lipid-coated
micelle
(CA@TLM)
loaded
with
stapled
peptide
(PalAno)
an
2A
receptor
(A2AR)
inhibitor
(CPI-444)
devised
enact
tumor-targeted
immunotherapy
overcome
adenosine-mediated
immune
suppression
simultaneously.
CA@TLM
accumulates
tumors
high
efficiency,
acidic
microenvironment
prompts
rapid
release
PalAno
CPI-444.
Subsequently,
induces
swift
membrane
lysis
cells
antigenic
materials.
Meanwhile,
CPI-444
blocks
activation
adenosine-A2AR
signaling
pathway.
This
combined
exhibits
pronounced
synergy
at
stalling
growth
metastasis
animal
models
for
triple-negative
breast
cancer
melanoma,
providing
novel
strategy
enhanced
Bioactive Materials,
Год журнала:
2023,
Номер
32, С. 66 - 97
Опубликована: Сен. 29, 2023
Ferroptosis
offers
a
novel
method
for
overcoming
therapeutic
resistance
of
cancers
to
conventional
cancer
treatment
regimens.
Its
effective
use
as
therapy
requires
precisely
targeted
approach,
which
can
be
facilitated
by
using
nanoparticles
and
nanomedicine,
their
enhance
ferroptosis
is
indeed
growing
area
research.
While
few
review
papers
have
been
published
on
iron-dependent
mechanism
inducers
that
partly
covers
nanoparticles,
there
need
comprehensive
focusing
the
design
magnetic
typically
supply
iron
ions
promote
simultaneously
enable
nanomedicine.
Furthermore,
locally
induce
combinational
with
diagnostic
resonance
imaging
(MRI).
The
remotely
controllable
nanocarriers
offer
highly
localized
image-guided
Here,
recent
developments
in
magnetically
manipulable
nanomedicine
medical
are
summarized.
This
also
highlights
advantages
current
state-of-the-art
Finally,
image
guided
apoptosis-based
enables
synergistic
tumor
discussed
clinical
translations.
ACS Nano,
Год журнала:
2024,
Номер
18(19), С. 12261 - 12275
Опубликована: Апрель 29, 2024
Cancer
immunotherapy
holds
significant
promise
for
addressing
diverse
malignancies.
Nevertheless,
its
efficacy
remains
constrained
by
the
intricate
tumor
immunosuppressive
microenvironment.
Herein,
a
light-triggered
nanozyme
Fe-TCPP-R848-PEG
(Fe-MOF-RP)
was
designed
remodeling
The
Fe-TCPP-MOFs
were
utilized
not
only
as
core
catalysis
component
against
destruction
but
also
biocompatible
delivery
vector
of
an
immunologic
agonist,
improving
long
circulation
and
enrichment.
Concurrently,
it
catalyzes
decomposition
H2O2
within
tumor,
yielding
oxygen
to
augment
photodynamic
therapy.
induced
ferroptosis,
in
synergy
with
therapy,
prompts
liberation
tumor-associated
antigens
from
cells
inducing
immunogenic
cell
death.
Phototriggered
on-demand
release
R848
agonists
stimulated
maturation
dendritic
reverted
tumor-promoting
M2
phenotypes
into
adoptive
M1
macrophages,
which
further
reshaped
Notably,
effectively
restrains
well-established
tumors,
such
B16F10
melanoma.
Moreover,
demonstrates
distal
tumor-inhibiting
effect
upon
situ
light
treatment.
What
is
more,
lung
metastasis
model,
elicits
robust
immune
memory,
conferring
enduring
protection
rechallenge.
Our
study
presents
straightforward
broadly
applicable
strategy
crafting
nanozymes
potential
thwart
cancer
recurrence
metastasis.
ACS Nano,
Год журнала:
2024,
Номер
18(19), С. 12295 - 12310
Опубликована: Май 2, 2024
Immune
checkpoint
blockade
(ICB)
has
brought
tremendous
clinical
progress,
but
its
therapeutic
outcome
can
be
limited
due
to
insufficient
activation
of
dendritic
cells
(DCs)
and
infiltration
cytotoxic
T
lymphocytes
(CTLs).
Evoking
immunogenic
cell
death
(ICD)
is
one
promising
strategy
promote
DC
maturation
elicit
T-cell
immunity,
whereas
low
levels
ICD
induction
solid
tumors
restrict
durable
antitumor
efficacy.
Herein,
we
report
a
genetically
edited
membrane-coated
cascade
nanozyme
(gCM@MnAu)
for
enhanced
cancer
immunotherapy
by
inducing
activating
the
stimulator
interferon
genes
(STING)
pathway.
In
tumor
microenvironment
(TME),
gCM@MnAu
initiates
reaction
generates
abundant
hydroxyl
(•OH),
resulting
in
improved
chemodynamic
therapy
(CDT)
boosted
activation.
addition,
released
Mn
ACS Nano,
Год журнала:
2024,
Номер
18(20), С. 12830 - 12844
Опубликована: Май 6, 2024
The
immunosuppressive
microenvironment
of
cervical
cancer
significantly
hampers
the
effectiveness
immunotherapy.
Herein,
PEGylated
manganese-doped
calcium
sulfide
nanoparticles
(MCSP)
were
developed
to
effectively
enhance
antitumor
immune
response
through
gas-amplified
metalloimmunotherapy
with
dual
activation
pyroptosis
and
STING
pathway.
bioactive
MCSP
exhibited
ability
rapidly
release
Ca2+,
Mn2+,
H2S
in
tumor
microenvironment.
disrupted
buffer
system
cells
by
interfering
oxidative
phosphorylation
pathway,
leading
overload-triggered
pyroptosis.
On
other
hand,
H2S-mediated
mitochondrial
dysfunction
further
promoted
DNA
(mtDNA),
enhancing
effect
Mn2+
on
cGAS-STING
signaling
axis
thereby
activating
immunosuppressed
dendritic
cells.
released
acted
as
an
important
synergist
between
Ca2+
modulating
mechanisms
bridge
innate
adaptive
responses.
combination
NPs
PD-1
immunotherapy
achieved
synergistic
effects
inhibited
growth.
This
study
reveals
potential
collaboration
gas
therapy
provides
idea
for
design
nanoimmunomodulators
rational
regulation
Acta Pharmaceutica Sinica B,
Год журнала:
2024,
Номер
14(8), С. 3432 - 3456
Опубликована: Май 13, 2024
The
advent
of
cancer
immunotherapy
has
imparted
a
transformative
impact
on
treatment
paradigms
by
harnessing
the
power
immune
system.
However,
challenge
practical
and
precise
targeting
malignant
cells
persists.
To
address
this,
engineered
nanoparticles
(NPs)
have
emerged
as
promising
solution
for
enhancing
targeted
drug
delivery
in
immunotherapeutic
interventions,
owing
to
their
small
size,
low
immunogenicity,
ease
surface
modification.
This
comprehensive
review
delves
into
contemporary
research
at
nexus
NP
engineering
immunotherapy,
encompassing
an
extensive
spectrum
morphologies
strategies
tailored
toward
optimizing
tumor
augmenting
therapeutic
effectiveness.
Moreover,
it
underscores
mechanisms
that
NPs
leverage
bypass
numerous
obstacles
encountered
regimens
probes
combined
potential
when
co-administered
with
both
established
novel
modalities.
Finally,
evaluates
existing
limitations
platforms
which
could
shape
path
future
advancements
this
field.
Abstract
Although
immunogenic
cell
death
(ICD)
inducers
evidently
enhance
the
effectiveness
of
immunotherapy,
their
potential
is
increasingly
restricted
by
development
apoptosis
resistance
in
tumor
cells,
poor
immunogenicity,
and
low
T‐cell
immune
responsiveness.
In
this
study,
for
first
time,
piezoelectrically
catalyzed
Mg
2+
‐doped
hydroxyapatite
(Mg‐HAP)
nanoparticles,
which
are
coated
with
a
mesoporous
silica
layer
loaded
ONC201
as
an
agonist
to
specifically
target
receptor
DR5
on
ultimately
developing
Mg‐HAP@MS/ONC201
nanoparticle
(MHMO
NP)
system,
engineered.
Owing
its
excellent
piezoelectric
properties,
MHMO
facilitates
release
significant
amount
reactive
oxygen
species
Ca
within
effectively
promoting
upregulation
expression
inducing
necroptosis
overcome
resistance.
Concurrently,
released
microenvironment
promotes
CD8
+
T
activation
response
antitumor
reaction
induced
ICD.
Using
RNA‐seq
analysis,
it
elucidated
that
can
activate
NF‐κB
pathway
under
catalysis,
thus
M1‐type
macrophage
polarization.
summary,
dual‐targeting
therapy
system
targets
both
cells
catalysis
designed.
This
holds
substantial
advancements
immunotherapy.
Advanced Functional Materials,
Год журнала:
2024,
Номер
34(33)
Опубликована: Март 31, 2024
Abstract
Dendritic
cell
(DC)
vaccines
have
shown
promising
effects
in
cancer
management,
while
low
activity
and
migration
rate
to
lymph
nodes
limit
their
clinical
application.
Here,
this
work
reports
a
bioink
DC
vaccine,
synthesized
by
3D
printing
methacryloyl
gelatin
encapsulate
DCs
tumor
cellular
vesicles
overexpressing
programmed
death
protein
1
(PD1‐CVs),
for
immunotherapy.
Compared
with
traditional
hydrogel,
the
porous
scaffold
significantly
improves
viability
of
from
∼16%
∼70%
after
7
days
culture
increases
proportion
released
into
about
fourfold.
The
PD1‐CVs
stimulate
maturation
block
PD
ligand‐1
(PD‐L1)
mature
cells,
synergistically
boosting
DC‐mediated
antitumor
immunity.
In
breast
mouse
models,
personalized
vaccine
developed
site‐specific
filling
resection
suppress
recurrence
extend
median
survival
time
45
days.
This
printed
offers
simple,
safe,
robust
strategy
enhanced
cell‐based
Advanced Healthcare Materials,
Год журнала:
2023,
Номер
12(26)
Опубликована: Авг. 4, 2023
Abstract
The
application
of
nanomaterials
in
healthcare
has
emerged
as
a
promising
strategy
due
to
their
unique
structural
diversity,
surface
properties,
and
compositional
diversity.
In
particular,
have
found
significant
role
improving
drug
delivery
inhibiting
the
growth
metastasis
tumor
cells.
Moreover,
recent
studies
highlighted
potential
modulating
microenvironment
(TME)
enhancing
activity
immune
cells
improve
therapy
efficacy.
Various
types
are
currently
utilized
carriers,
immunosuppressants,
activators,
immunoassay
reagents,
more
for
immunotherapy.
Necessarily,
used
immunotherapy
can
be
grouped
into
two
categories:
organic
inorganic
nanomaterials.
Though
both
shown
ability
achieve
purpose
immunotherapy,
composition
properties
result
differences
mechanisms
modes
action.
Organic
further
divided
polymers,
cell
membranes,
nanoemulsion‐modified,
hydrogel
forms.
At
same
time,
broadly
classified
nonmetallic
metallic
current
work
aims
explore
action
these
different
prospects
promoting